We have Ranked, Sorted and Summarized the Latest Clinical Articles.

1Intake of meat mutagens and risk of prostate cancer in a cohort of U.S. health professionalsCancer Epidemiology, Biomarkers & Prevention, August 04, 2015  Clinical Article
2No association of ApoE genotype with risk of prostate cancer: A nested case-control studyCancer Epidemiology, Biomarkers & Prevention, August 04, 2015  Clinical Article
3Salvage radiation therapy improves metastasis-free survival for clinically aggressive and indolent prostate cancer recurrences after radical prostatectomyAmerican Journal of Clinical Oncology, August 04, 2015  Clinical Article
4Treatment patterns for older veterans with localized prostate cancerCancer Epidemiology, August 04, 2015  Clinical Article
5Are biomarkers evaluated in biopsy specimens predictive of prostate cancer aggressiveness?Journal of Cancer Research & Clinical Oncology, August 04, 2015  Clinical Article
6A multi-institutional analysis of outcomes in patients with clinically node positive urothelial bladder cancer treated with induction chemotherapy and radical cystectomyThe Journal of Urology, August 04, 2015  Clinical Article
7Prostatic arterial embolization vs open prostatectomy: A 1-year matched-pair analysis of functional outcomes and morbiditiesUrology, August 04, 2015  Clinical Article
8Rural vs. urban disparities in association with lower urinary tract symptoms and benign prostatic hyperplasia in ageing men, NHANES 2001–2008International Journal of Clinical Practice, August 04, 2015  Clinical Article
9Residual parenchymal volume, not warm ischemia time, predicts ultimate renal functional outcomes in patients undergoing partial nephrectomyUrology, August 04, 2015  Clinical Article
10Carboplatin, methotrexate, vinblastine, and epirubicin (M-VECa) as salvage treatment in patients with advanced bladder cancer: a phase II studyAnti-Cancer Drugs, August 04, 2015  Clinical Article

Show Me:

We have Ranked, Sorted and Summarized the Latest Clinical Articles.

1Announcement: Additional guidance online for providers regarding 9-valent HPV vaccine use among persons who previously received HPV vaccinationMorbidity and Mortality Weekly Report, August 04, 2015
2The uneasy, unbreakable link of money, medicineBrown University News, August 04, 2015
3Structures reveal basis of recurring urinary tract infectionsDuke University Health & Medicine News, August 03, 2015
4Prostate cancer is five different diseasesCancer Research UK News, August 03, 2015
5Prostate 'organoid' hints at how early BPA exposure may increase cancer riskUniversity of Illinois at Chicago Health News, July 31, 2015
6NUS team discovers novel way of protecting male reproductive cells and hails new approach to addressing male infertilityNational University of Singapore News, July 30, 2015
7“Cancer Driver Gene” reduces metastasis in prostate cancerMedical University of Vienna, July 29, 2015
8Fertility after cancer: Young women less likely to be told about optionsFred Hutchinson Cancer Research Center News, July 28, 2015
9For prostate cancer patients, risk-specific therapies now more the normUCSF News, July 27, 2015
10Investigating the role of enzymes in pelvic painNorthwestern Medicine News, July 23, 2015

Show Me:

NSAID use inversely related to prostate cancer incidence and mortality

Based on a meta-analysis reported in BMC Medicine, NSAID use is associated with a decreased risk of prostate cancer (OR=0.92 [total] and 0.81 [advanced]) and prostate cancer-specific mortality (HR=0.86 [total] and 0.81 [advanced]).

GALNT4 predicts survival in patients with ccRCC

As reported in the Journal of Urology, N-acetylgalactosaminyltransferase 4 (GALNT4) levels are decreased in tumor specimens from patients with clear cell renal cell carcinoma (ccRCC; n=104) compared to peritumoral specimens. Decreased expression of GALNT4 is associated with poor OS (OR=3.08) and RFS (OR=2.17). Further, GALNT4 is negatively correlated with tumor size, necrosis, and TNM stage.

Chromogranin A staining as a biomarker for prostate adenocarcinoma

As reported in The Prostate, chromogranin A (CgA) staining, an indicator of neuroendocrine differentiation, is associated with decreased biochemical control, clinical failure, increased distant metastases, and decreased cause-specific survival in patients with prostate adenocarcinoma and a GS ≥ 7 (n=285). The median follow-up was 6.5 y. CgA staining was present in 31% of specimens. The 10-y distant metastases rate in specimens with <1% and >1% CgA staining was 8% and 48%, respectively. The 10-y cause-specific survival in specimens with <1% and >1% CgA staining was 95% vs. 76%, respectively.

Are YOU the Smartest Doc in America?

The Smartest Doc from MDLinx keeps you current with a competitive edge, pitting colleagues against one other for the title of The Smartest Doc in America.

Take the Challenge

Clinical Pearls

Clinical Pearl from Smartest DocMeasurement of urolithiasis risk factors may be affected by urine specimen collection and storage.

Clinical Pearl from Smartest DocA higher elastic modulus is independently associated with voiding symptoms.

Clinical Pearl from Smartest DocThe Emergency Department is being increasingly used as a pathway for management of acute conditions such as UTIs.

Clinical Articles in Urology

MDLinx Urology News

Search today's latest urology news, updated daily from over 2,000 peer-reviewed journals, at MDLinx. Stay current with up-to-the-minute reproductive information and urinary related clinical research covering all aspects of the male and female urinary tract system and the male reproductive organs. Our diligent team of MDLinx physician editors rigorously research a wide range of urology medical journals dedicated to the kidney, bladder, penis, urethra and prostate as well as pediatric urology, prostate cancer, kidney stones, infections and sexually transmitted diseases (STDs), urologic imaging, ureteral disorders, voiding and incontinence, infertility and laparoscopy. They then summarize and rank the articles by clinical impact to provide the most valuable literature to make sure any urologist, and all members of their healthcare team, can stay current with the latest in neurological clinical research.

Be Ready for Upcoming 2015 Board Exams!

Be prepared for board reviews with confidence with 1000s of board exam style questions. Prepare Here